{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T03:34:10Z","timestamp":1789184050685,"version":"build-2803163510"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,18]],"date-time":"2025-07-18T00:00:00Z","timestamp":1752796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,18]],"date-time":"2025-07-18T00:00:00Z","timestamp":1752796800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Hebei Province 2024 annual medical science research topic","award":["20240024"],"award-info":[{"award-number":["20240024"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-11495-9","type":"journal-article","created":{"date-parts":[[2025,7,18]],"date-time":"2025-07-18T14:12:32Z","timestamp":1752847952000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["The effect of PDLIM7 on cell proliferation, migration, and drug sensitivity in clear cell renal cell carcinoma"],"prefix":"10.1038","volume":"15","author":[{"given":"Chong","family":"Shen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Zhuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianying","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,18]]},"reference":[{"key":"11495_CR1","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1016\/j.eururo.2019.02.011","volume":"75","author":"B Ljungberg","year":"2019","unstructured":"Ljungberg, B. et al. European association of urology guidelines on renal cell carcinoma: The 2019 update. Eur. Urol. 75, 799\u2013810 (2019).","journal-title":"Eur. Urol."},{"key":"11495_CR2","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1093\/annonc\/mdz056","volume":"30","author":"B Escudier","year":"2019","unstructured":"Escudier, B. et al. Renal cell carcinoma: Esmo clinical practice guidelines for diagnosis, treatment and follow-up\u2020. Ann. Oncol. 30, 706\u2013720 (2019).","journal-title":"Ann. Oncol."},{"key":"11495_CR3","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1146\/annurev-med-041916-124132","volume":"69","author":"M Parikh","year":"2018","unstructured":"Parikh, M. & Lara, P. N. J. Modern systemic therapy for metastatic renal cell carcinoma of the clear cell type. Annu Rev Med. 69, 209\u2013221 (2018).","journal-title":"Annu Rev Med."},{"key":"11495_CR4","doi-asserted-by":"publisher","first-page":"349","DOI":"10.21873\/cgp.20265","volume":"18","author":"UH Weidle","year":"2021","unstructured":"Weidle, U. H. & Nopora, A. Clear cell renal carcinoma: Micrornas with efficacy in preclinical in vivo models. Cancer Genom Proteom. 18, 349\u2013368 (2021).","journal-title":"Cancer Genom Proteom."},{"key":"11495_CR5","doi-asserted-by":"publisher","first-page":"12691","DOI":"10.1074\/jbc.271.22.12691","volume":"271","author":"K Durick","year":"1996","unstructured":"Durick, K., Wu, R. Y., Gill, G. N. & Taylor, S. S. Mitogenic signaling by Ret\/Ptc2 requires association with enigma via a lim domain. J. Biol. Chem. 271, 12691\u201312694 (1996).","journal-title":"J. Biol. Chem."},{"key":"11495_CR6","doi-asserted-by":"publisher","first-page":"31029","DOI":"10.1074\/jbc.271.49.31029","volume":"271","author":"S Kuroda","year":"1996","unstructured":"Kuroda, S. et al. Protein-protein interaction of zinc finger lim domains with protein kinase C. J. Biol. Chem. 271, 31029\u201331032 (1996).","journal-title":"J. Biol. Chem."},{"key":"11495_CR7","doi-asserted-by":"publisher","first-page":"15934","DOI":"10.1074\/jbc.271.27.15934","volume":"271","author":"R Wu","year":"1996","unstructured":"Wu, R. et al. Specificity of lim domain interactions with receptor tyrosine kinases. J. Biol. Chem. 271, 15934\u201315941 (1996).","journal-title":"J. Biol. Chem."},{"key":"11495_CR8","doi-asserted-by":"publisher","first-page":"19807","DOI":"10.1074\/jbc.274.28.19807","volume":"274","author":"Q Zhou","year":"1999","unstructured":"Zhou, Q., Ruiz-Lozano, P., Martone, M. E. & Chen, J. Cypher, a striated muscle-restricted Pdz and lim domain-containing protein, binds to alpha-actinin-2 and protein kinase C. J. Biol. Chem. 274, 19807\u201319813 (1999).","journal-title":"J. Biol. Chem."},{"key":"11495_CR9","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/s13578-023-00993-w","volume":"13","author":"Z Wu","year":"2023","unstructured":"Wu, Z. et al. Tpm2 attenuates progression of prostate cancer by blocking Pdlim7-mediated nuclear translocation of Yap1. Cell Biosci. 13, 39 (2023).","journal-title":"Cell Biosci."},{"key":"11495_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.tranon.2023.101830","volume":"40","author":"Q Liu","year":"2024","unstructured":"Liu, Q. et al. H3K27 acetylation activated-Pdlim7 promotes castration-resistant prostate cancer progression by inducing O-glycosylation of Yap1 protein. Transl. Oncol. 40, 101830 (2024).","journal-title":"Transl. Oncol."},{"key":"11495_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.matbio.2022.11.005","volume":"115","author":"Y Lu","year":"2023","unstructured":"Lu, Y. et al. Calponin 1 increases cancer-associated fibroblasts-mediated matrix stiffness to promote chemoresistance in gastric cancer. Matrix Biol. 115, 1\u201315 (2023).","journal-title":"Matrix Biol."},{"key":"11495_CR12","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkv007","volume":"43","author":"ME Ritchie","year":"2015","unstructured":"Ritchie, M. E. et al. Limma powers differential expression analyses for Rna-sequencing and microarray studies. Nucleic Acids Res. 43, e47 (2015).","journal-title":"Nucleic Acids Res."},{"key":"11495_CR13","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1007\/978-1-4939-3578-9_6","volume":"1418","author":"Z Wang","year":"2016","unstructured":"Wang, Z., Jensen, M. A. & Zenklusen, J. C. A practical guide to the cancer genome atlas (Tcga). Methods Mol. Biol. (Clifton, N.J.) 1418, 111\u2013141 (2016).","journal-title":"Methods Mol. Biol. (Clifton, N.J.)"},{"key":"11495_CR14","doi-asserted-by":"publisher","first-page":"W182","DOI":"10.1093\/nar\/gkm321","volume":"35","author":"Y Moriya","year":"2007","unstructured":"Moriya, Y., Itoh, M., Okuda, S., Yoshizawa, A. C. & Kanehisa, M. KAAS: An automatic genome annotation and pathway reconstruction server. Nucleic. Acids. Res. 35, W182\u2013W185 (2007).","journal-title":"Nucleic. Acids. Res."},{"key":"11495_CR15","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.canlet.2003.10.008","volume":"205","author":"MO Garc\u00eda-Fern\u00e1ndez","year":"2004","unstructured":"Garc\u00eda-Fern\u00e1ndez, M. O. et al. Pacap expression and distribution in human breast cancer and healthy tissue. Cancer Lett. 205, 189\u2013195 (2004).","journal-title":"Cancer Lett."},{"key":"11495_CR16","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2119854119","volume":"119","author":"H Xie","year":"2022","unstructured":"Xie, H. et al. Usp13 promotes deubiquitination of Zhx2 and tumorigenesis in kidney cancer. P. Natl. Acad. Sci. U. S. A. 119, e2119854119 (2022).","journal-title":"P. Natl. Acad. Sci. U. S. A."},{"key":"11495_CR17","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1038\/s41568-021-00380-y","volume":"21","author":"L Fabbri","year":"2021","unstructured":"Fabbri, L., Chakraborty, A., Robert, C. & Vagner, S. The plasticity of Mrna translation during cancer progression and therapy resistance. Nat. Rev. Cancer 21, 558\u2013577 (2021).","journal-title":"Nat. Rev. Cancer"},{"key":"11495_CR18","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1038\/s41568-023-00586-2","volume":"23","author":"C Liu","year":"2023","unstructured":"Liu, C. et al. Mrna-based cancer therapeutics. Nat. Rev. Cancer 23, 526\u2013543 (2023).","journal-title":"Nat. Rev. Cancer"},{"key":"11495_CR19","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.cca.2021.09.013","volume":"523","author":"M Zhang","year":"2021","unstructured":"Zhang, M. et al. Circrna-Mirna-Mrna in breast cancer. Clin. Chim. Acta Int. J. Clin. Chem. 523, 120\u2013130 (2021).","journal-title":"Clin. Chim. Acta Int. J. Clin. Chem."},{"key":"11495_CR20","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1038\/nrd1578","volume":"3","author":"KK Dev","year":"2004","unstructured":"Dev, K. K. Making protein interactions druggable: Targeting Pdz domains. Nat. Rev. Drug Discov. 3, 1047\u20131056 (2004).","journal-title":"Nat. Rev. Drug Discov."},{"key":"11495_CR21","first-page":"6124","volume":"11","author":"L Cui","year":"2019","unstructured":"Cui, L. et al. Prognostic value of the pdlim family in acute myeloid leukemia. Am. J. Transl. Res. 11, 6124\u20136131 (2019).","journal-title":"Am. J. Transl. Res."},{"key":"11495_CR22","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2320867121","volume":"121","author":"C Hu","year":"2024","unstructured":"Hu, C. et al. Oga mutant aberrantly hydrolyzes O-Glcnac modification from Pdlim7 to modulate P53 and cytoskeleton in promoting cancer cell malignancy. P. Natl. Acad. Sci. U. S. A. 121, e1974100175 (2024).","journal-title":"P. Natl. Acad. Sci. U. S. A."},{"key":"11495_CR23","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1186\/s12967-023-03913-1","volume":"21","author":"J Xu","year":"2023","unstructured":"Xu, J., Wang, Y., Jiang, J., Yin, C. & Shi, B. Adam12 promotes clear cell renal cell carcinoma progression and triggers Emt Via Egfr\/Erk signaling pathway. J. Transl. Med. 21, 56 (2023).","journal-title":"J. Transl. Med."},{"key":"11495_CR24","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1089\/thy.2023.0497","volume":"34","author":"F Yang","year":"2024","unstructured":"Yang, F. et al. Pdlim7 promotes tumor metastasis in papillary thyroid carcinoma via stabilizing focal adhesion kinase protein. Thyroid 34, 598\u2013610 (2024).","journal-title":"Thyroid"},{"key":"11495_CR25","first-page":"e50","volume":"138","author":"DPP Argyris","year":"2024","unstructured":"Argyris, D. P. P., Van Koevering, D. K. K. & Iwenofu, P. O. H. Novel Tert::Pdlim7 gene fusion in a skull-based soft tissue myoepithelial carcinoma. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. 138, e50 (2024).","journal-title":"Oral Surg. Oral Med. Oral Pathol. Oral Radiol."},{"key":"11495_CR26","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2020.21869","volume":"4","author":"S Dudani","year":"2021","unstructured":"Dudani, S. et al. Evaluation of clear cell, papillary, and chromophobe renal cell carcinoma metastasis sites and association with survival. JAMA Netw. Open 4, e2021869 (2021).","journal-title":"JAMA Netw. Open"},{"key":"11495_CR27","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1146\/annurev-pathol-012414-040306","volume":"10","author":"IJ Frew","year":"2015","unstructured":"Frew, I. J. & Moch, H. A clearer view of the molecular complexity of clear cell renal cell carcinoma. Annu. Rev. Pathol. 10, 263\u2013289 (2015).","journal-title":"Annu. Rev. Pathol."},{"key":"11495_CR28","first-page":"3241","volume":"33","author":"CS Ang","year":"2013","unstructured":"Ang, C. S. et al. C-Met and Hgf Mrna expression in hepatocellular carcinoma: Correlation with clinicopathological features and survival. Anticancer Res. 33, 3241\u20133245 (2013).","journal-title":"Anticancer Res."},{"key":"11495_CR29","first-page":"8357","volume":"14","author":"X Fan","year":"2022","unstructured":"Fan, X. et al. Identify Mirna-Mrna regulation pairs to explore potential pathogenesis of lung adenocarcinoma. Aging 14, 8357\u20138373 (2022).","journal-title":"Aging"},{"key":"11495_CR30","doi-asserted-by":"publisher","first-page":"249","DOI":"10.7314\/APJCP.2016.17.1.249","volume":"17","author":"N Moazzezy","year":"2016","unstructured":"Moazzezy, N. et al. Relationship between Erb-B2 Mrna expression in blood and tissue of invasive ductal carcinoma breast cancer patients and clinicopathological characteristics of the tumors. Asian Pac. J. Cancer Prev. APJCP 17, 249\u2013254 (2016).","journal-title":"Asian Pac. J. Cancer Prev. APJCP"},{"key":"11495_CR31","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.yexmp.2018.01.004","volume":"104","author":"R Wahab","year":"2018","unstructured":"Wahab, R. et al. Expression of Gaec1 Mrna and protein and its association with clinical and pathological parameters of patients with colorectal adenocarcinoma. Exp. Mol. Pathol. 104, 71\u201375 (2018).","journal-title":"Exp. Mol. Pathol."},{"key":"11495_CR32","doi-asserted-by":"crossref","unstructured":"Loh, C. et al. The E-Cadherin and N-Cadherin switch in epithelial-to-mesenchymal transition: signaling, therapeutic implications, and challenges. Cells-Basel. 8, (2019).","DOI":"10.3390\/cells8101118"},{"key":"11495_CR33","doi-asserted-by":"publisher","first-page":"3033","DOI":"10.1007\/s00018-011-0735-1","volume":"68","author":"A Satelli","year":"2011","unstructured":"Satelli, A. & Li, S. Vimentin in cancer and its potential as a molecular target for cancer therapy. Cell. Mol. Life Sci. CMLS 68, 3033\u20133046 (2011).","journal-title":"Cell. Mol. Life Sci. CMLS"},{"key":"11495_CR34","doi-asserted-by":"crossref","unstructured":"Zhang, X., Wu, H., Yan, X., Ma, J. & Chen, Z. Ltb4R promotes the occurrence and progression of clear cell renal cell carcinoma (Ccrcc) by regulating the Akt\/Mtor signaling pathway. Cells-Basel. 11, (2022).","DOI":"10.3390\/cells11223606"},{"key":"11495_CR35","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.ctrv.2018.07.009","volume":"70","author":"MB Atkins","year":"2018","unstructured":"Atkins, M. B. & Tannir, N. M. Current and emerging therapies for first-line treatment of metastatic clear cell renal cell carcinoma. Cancer Treat Rev. 70, 127\u2013137 (2018).","journal-title":"Cancer Treat Rev."},{"key":"11495_CR36","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.eururo.2023.04.003","volume":"84","author":"BH Cotta","year":"2023","unstructured":"Cotta, B. H. et al. Current landscape of genomic biomarkers in clear cell renal cell carcinoma. Eur. Urol. 84, 166\u2013175 (2023).","journal-title":"Eur. Urol."},{"key":"11495_CR37","doi-asserted-by":"publisher","first-page":"17009","DOI":"10.1038\/nrdp.2017.9","volume":"3","author":"JJ Hsieh","year":"2017","unstructured":"Hsieh, J. J. et al. Renal cell carcinoma. Nat. Rev. Dis. Primers. 3, 17009 (2017).","journal-title":"Nat. Rev. Dis. Primers."},{"key":"11495_CR38","doi-asserted-by":"publisher","first-page":"2445","DOI":"10.1158\/1078-0432.CCR-15-2631","volume":"22","author":"DJ Kwiatkowski","year":"2016","unstructured":"Kwiatkowski, D. J. et al. Mutations in Tsc1, Tsc2, and Mtor are associated with response to rapalogs in patients with metastatic renal cell carcinoma. Clin. Cancer Res. 22, 2445\u20132452 (2016).","journal-title":"Clin. Cancer Res."},{"key":"11495_CR39","doi-asserted-by":"publisher","first-page":"3526","DOI":"10.1172\/JCI86120","volume":"126","author":"J Xu","year":"2016","unstructured":"Xu, J. et al. Mechanistically distinct cancer-associated mtor activation clusters predict sensitivity to rapamycin. J. Clin. Investig. 126, 3526\u20133540 (2016).","journal-title":"J. Clin. Investig."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-11495-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-11495-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-11495-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,7]],"date-time":"2025-09-07T14:28:02Z","timestamp":1757255282000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-11495-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,18]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["11495"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-11495-9","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,18]]},"assertion":[{"value":"25 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"26111"}}